Evolva Holding S.A. (Ticker: ELVAF) develops and commercializes sustainable ingredients using proprietary biotechnology processes for the flavor, fragrance, cosmetics, and life sciences industries. The company offers a portfolio of nature-identical ingredients, including Valencene for nootkatone production, nootkatone as a natural insect repellent and flavor compound, sclareol for fragrance applications, and specialty biotech-derived products such as resveratrol, vanillin alternatives, and saffron components; these are produced via fermentation technology that enables scalable, environmentally friendly manufacturing without reliance on traditional plant extraction or chemical synthesis. Evolva serves customers in food and beverage, personal care, consumer health, and pharmaceutical sectors, with operations spanning Europe, North America, and Asia. Founded in 2004 and headquartered in Reinach, Switzerland, the company focuses on high-value, biotech-enabled molecules targeting premium markets demanding natural and sustainable solutions. In recent developments, Evolva has pursued strategic expansions in its nootkatone platform through partnerships for commercial scaling and continued advancements in its fermentation technology suite to broaden ingredient offerings amid growing demand for biotech flavors and repellents.